The effect of Cerebrolysin in cerebral palsy

Phase 2

• Conditions: Condition 1: Cerebral Palsy. Condition 2: Spastic diplegic cerebral palsy. Condition 3: Spastic quadriplegic cerebral palsy. Condition 4: Spastic hemiplegic cerebral palsy. Condition 5: Dyskinetic cerebral palsy. Condition 6: Ataxic cerebral palsy. Condition 7: Other cerebral palsy. Condition 8: Cerebral palsy, unspecified. Condition 9: Spastic diplegic cerebral palsy.; Excl: hereditary spastic paraplegia; Congenital spastic paralysis (cerebral) Spastic cerebral palsy NOS; Spastic tetraplegic cerebral palsy; Spastic hemiplegic cerebral palsy; Athetoid cerebral palsy Dystonic cerebral palsy; Ataxic cerebral palsy; Mixed cerebral palsy syndromes; Cerebral palsy NOS

• Registration Number: IRCT201107226907N3
• Lead Sponsor: Vice Chancellor for Reseach, Tehran university of medical sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 26

Inclusion Criteria

Inclusion criteria includes:

1. Participants must be 6 to 12 years old.

2. Participants must be free of grand mal seizure attacks.

Exclusion criteria includes:

1. Participants with diagnosis of cerebral palsy and grand mal seizure attacks co-morbidity have been excluded of the study.

2. Participants with renal failure disorder would not be participated in the study.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Degree of improvement in spapsticity. Timepoint: Before intervention, At the end of the first month of treatment course, At the end of third month of second course of intervention. Method of measurement: Asworth Scoring.